Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Post by ourrugon May 15, 2019 3:34pm
107 Views
Post# 29749811

Detailed MMCAP Hedging Strategy

Detailed MMCAP Hedging Strategy
MMCAP shorted another 620,367 shares in Q1 - for a total short position of borrowed shares of 8,620,689 shares. They will need to cover this amount by March 1st, 2020.
 
On April 25th, MMCAP had to buy in the open market 49,623 shares at a price between 0.69 and 0.73. Most likely from an oversold position.
 
Based on the average share prices dating back to May 2018 - MMCAP's short position, and current market value may well have a paper value of over $2 million at 0.60.
 
They are hedged for 2 million warrants at 0.90 - that they could cover - and vulnerable up to $1.50 on the rest of their borrowed shares between now and March 1st.
 
The lower the price the better for MMCAP until then.
 
MMCAP's manipulation in full detail:
 
"How a handful of hedge funds cornered cannabis financing — and made a killing in the process -
The short-term nature of many hedge funds' investments raise important questions about the cannabis sector, and may give retail investors investors pause"
 
<< Previous
Bullboard Posts
Next >>